New ultrasensitive detection technologies and techniques for use in microdosing studies
- PMID: 21083172
- DOI: 10.4155/bio.09.40
New ultrasensitive detection technologies and techniques for use in microdosing studies
Abstract
In a microdosing study, subpharmacologically active doses of drug are given to human volunteers at an early stage of development in order to obtain preliminary pharmacokinetic data. The very low doses of drug administered (≤100 µg) consequently lead to very low concentrations of drug appearing in the body and therefore highly sensitive analytical techniques are required. There are three such analytical technologies currently used in microdosing studies: PET, liquid chromatography (LC)-tandem mass spectrometry (MS/MS) and accelerator mass spectrometry (AMS). Both PET and AMS employ radioisotopic tracers. PET is an imaging technique and AMS is an extremely sensitive isotope ratio method, able to measure drug concentrations in the ag/ml range. LC-MS/MS does not require the presence of an isotopic tracer and its sensitivity is in the pg/ml range. This review examines each of these three analytical modalities in the context of performing microdosing studies.
Similar articles
-
Big physics, small doses: the use of AMS and PET in human microdosing of development drugs.Nat Rev Drug Discov. 2003 Mar;2(3):233-40. doi: 10.1038/nrd1037. Nat Rev Drug Discov. 2003. PMID: 12612650 Review.
-
Microdosing for early biokinetic studies in humans.Radiat Prot Dosimetry. 2010 Apr-May;139(1-3):348-52. doi: 10.1093/rpd/ncq029. Epub 2010 Feb 18. Radiat Prot Dosimetry. 2010. PMID: 20167793
-
Practical experience of using human microdosing with AMS analysis to obtain early human drug metabolism and PK data.Bioanalysis. 2010 Mar;2(3):429-40. doi: 10.4155/bio.10.6. Bioanalysis. 2010. PMID: 21083253 Review.
-
Microdosing: a valuable tool for accelerating drug development and the role of bioanalytical methods in meeting the challenge.Bioanalysis. 2009 Oct;1(7):1293-305. doi: 10.4155/bio.09.107. Bioanalysis. 2009. PMID: 21083052 Review.
-
Novel strategies for microdose studies using non-radiolabeled compounds.Adv Drug Deliv Rev. 2011 Jun 19;63(7):532-8. doi: 10.1016/j.addr.2011.02.004. Epub 2011 Feb 21. Adv Drug Deliv Rev. 2011. PMID: 21345359 Review.
Cited by
-
A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamil.Clin Pharmacokinet. 2011 Feb;50(2):111-20. doi: 10.2165/11537250-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21142292 Free PMC article. Clinical Trial.
-
A microdose study of ¹⁴C-AR-709 in healthy men: pharmacokinetics, absolute bioavailability and concentrations in key compartments of the lung.Eur J Clin Pharmacol. 2013 Sep;69(9):1673-82. doi: 10.1007/s00228-013-1528-2. Epub 2013 Jun 6. Eur J Clin Pharmacol. 2013. PMID: 23739997 Clinical Trial.
-
Approaches using molecular imaging technology -- use of PET in clinical microdose studies.Adv Drug Deliv Rev. 2011 Jun 19;63(7):539-46. doi: 10.1016/j.addr.2010.09.011. Epub 2010 Sep 29. Adv Drug Deliv Rev. 2011. PMID: 20887762 Free PMC article. Review.
-
Combining Isotopic Tracer Techniques to Increase Efficiency of Clinical Pharmacokinetic Trials in Oncology.Drugs R D. 2020 Jun;20(2):147-154. doi: 10.1007/s40268-020-00304-5. Drugs R D. 2020. PMID: 32300967 Free PMC article. Review.
-
Antibody-based imaging strategies for cancer.Cancer Metastasis Rev. 2014 Sep;33(2-3):809-22. doi: 10.1007/s10555-014-9505-5. Cancer Metastasis Rev. 2014. PMID: 24913898 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical